Sangamo Therapeutics
SGMO
#6405
Rank
โ‚ฌ0.54 B
Marketcap
2,61ย โ‚ฌ
Share price
13.77%
Change (1 day)
563.59%
Change (1 year)

Sangamo Therapeutics (SGMO) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚ฌ64.28 Million

According to Sangamo Therapeutics 's latest financial reports the company's total liabilities are โ‚ฌ64.28 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sangamo Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ74.56 M-70.1%
2022-12-31โ‚ฌ0.24 B-18.5%
2021-12-31โ‚ฌ0.30 B-14.68%
2020-12-31โ‚ฌ0.35 B96.22%
2019-12-31โ‚ฌ0.18 B-6.28%
2018-12-31โ‚ฌ0.19 B136.78%
2017-12-31โ‚ฌ82.37 M299.38%
2016-12-31โ‚ฌ20.62 M-9.05%
2015-12-31โ‚ฌ22.67 M-24.6%
2014-12-31โ‚ฌ30.07 M117.15%
2013-12-31โ‚ฌ13.85 M3.88%
2012-12-31โ‚ฌ13.33 M140.36%
2011-12-31โ‚ฌ5.54 M4.04%
2010-12-31โ‚ฌ5.33 M-51.21%
2009-12-31โ‚ฌ10.92 M22.67%
2008-12-31โ‚ฌ8.9 M10.44%
2007-12-31โ‚ฌ8.06 M50.44%
2006-12-31โ‚ฌ5.36 M-43.13%
2005-12-31โ‚ฌ9.42 M444.71%
2004-12-31โ‚ฌ1.73 M38.72%
2003-12-31โ‚ฌ1.24 M-34.15%
2002-12-31โ‚ฌ1.89 M-37.27%
2001-12-31โ‚ฌ3.02 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ32.80 B 50,938.60%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.86 B 5,919.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ77.29 B 120,141.19%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ10.12 B 15,644.91%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ37.60 B 58,390.57%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ100.26 B 155,876.29%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.33 B 1,974.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ63.96 B 99,406.66%๐Ÿ‡บ๐Ÿ‡ธ USA